1)日本ペインクリニック学会神経障害性疼痛薬物療法ガイドライン改訂版作成ワーキンググループ(編):神経障害性疼痛薬物療法ガイドライン 改訂第2版,真興交易医書出版部,2016
2)Treede RD, et al:Neuropathic pain;Redefinition and a grading system for clinical and research purposes. Neurology 70:1630-1635, 2008 PMID 18003941
3)Finnerup NB, et al:Pharmacotherapy for neuropathic pain in adults;A systemic review and meta-analysis. Lancet Neurol 14:162-173, 2015 PMID 25575710
4)Baba M, et al:Mirogabalin for the treatment of diabetic peripheral neuropathic pain;A randomized, double-blind, placebo-contralled phase Ⅲ study in Asian patients. J Diabetes Investig 10:1299-1306, 2019 PMID 30672128
5)Yasuda H, et al:Superiority of duloxetine to placebo in improving diabetic neuropathic pain;Results of a randomized controlled trial in Japan. J Diabet Invest 2:132-139, 2011 PMID 24843472
6)山村秀夫,他:ノイロトロピン錠の帯状疱疹後疼痛に対する効果—プラセボ錠を対象薬とした他施設二重盲検試験.医学のあゆみ147:651-664, 1988